Skip to main content

Table 2 Correlations the clinical characteristics among CNR1 between HCC with or without cirrhosis in TCGA

From: In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC

Variables

N

Non-cirrhotic HCC

N

Cirrhotic HCC

CNR1

CNR1

Low/high expression case (n)

p value

Low/high expression case (n)

p value

Gender

 Male

82

44/38

0.282

61

31/30

0.635

 Female

50

22/28

18

8/10

Age at diagnosis

 ≥ 60

80

38/42

0.476

36

17/19

0.650

 < 60

52

28/24

42

22/20

 NA

0

0

1

0/1

T stage

 T1/T2

97

48/49

1.000

70

35/35

0.712

 T3/T4

33

17/16

8

3/5

 TX

1

1/0

0

0/0

 NA

1

0/1

1

1/0

N stage

 N0

91

49/42

0.259

57

29/28

1.000

 N1

1

0/1

1

0/1

 NX

40

17/23

20

10/10

 NA

0

0/0

1

0/1

M stage

 M0

90

46/44

0.529

62

31/31

0.830

 M1

4

3/1

0

0/0

 MX

38

17/21

17

8/9

Pathologic stage

 I/II

91

44/47

0.755

67

35/32

0.478

 III/IV

33

17/16

9

3/6

 NA

8

5/3

3

1/2

Vascular invasion

 None

87

38/49

0.127

52

26/26

0.900

 Micro

33

18/15

22

10/12

 Macro

6

5/1

2

1/1

 NA

6

5/1

3

2/1

HBV infection

 Yes

38

25/13

0.036

36

20/16

0.358

 No

88

40/48

40

18/22

 NA

6

1/5

3

1/2

HCV infection

 Yes

14

6/8

0.488

20

13/7

0.118

 No

112

59/53

56

25/31

 NA

6

1/5

3

1/2

  1. NA not applicable
  2. The significant p value is marked with italic type